APOE and Alzheimer disease: The lifetime risk of AD is more than 50% for ApoE4 homozygotes and 20-30% for heterozygotes for ApoE3 and ApoE4, whereas the overall risk is 11% for men and 14% for women, regardless of the ApoE genotype [122].